Ascend Wellness Holdings (AAWH) EBT Growth (1y) (2021 - 2026)
Ascend Wellness Holdings (AAWH) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -324.14% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -1.93% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -8.74% |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 70.52% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 1.69% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 124.00% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | -23.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.47% |
| Mar 31, 2026 | -113.76% |
| Dec 31, 2025 | -440.92% |
| Sep 30, 2025 | 26.73% |
| Jun 30, 2025 | -29.94% |
| Mar 31, 2025 | -45.53% |
| Dec 31, 2024 | 18.55% |
| Sep 30, 2024 | -309.59% |
| Jun 30, 2024 | -273.50% |
| Mar 31, 2024 | 33.14% |
| Dec 31, 2023 | -136.64% |
| Sep 30, 2023 | 20.58% |
| Jun 30, 2023 | 157.51% |
| Mar 31, 2023 | 59.17% |
| Dec 31, 2022 | 61.41% |
| Sep 30, 2022 | -690.54% |
| Jun 30, 2022 | 70.52% |
| Mar 31, 2022 | 47.24% |
| Dec 31, 2021 | -1,472.90% |
| Sep 30, 2021 | -198.76% |